Last reviewed · How we verify

NCT03374813

Efficacy of MimetikOss in Alveolar Ridge Preservation Previous to Implant Placement

Status unknown NA Last updated 25 March 2021
What this trial tests

NA trial testing MimetikOss (bone grafting surgery) in Alveolar Ridge Preservation in 102 participants. Status unknown.

Timeline
16 November 2017
Primary endpoint
22 April 2021
15 December 2021

Quick facts

Lead sponsorMimetis Biomaterials S.L.
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment102
Start date16 November 2017
Primary completion22 April 2021
Estimated completion15 December 2021
Sites8 locations across Chile, Spain

Drugs / interventions tested

Conditions studied

Sponsor

Mimetis Biomaterials S.L.

Who can join

18 and older, any sex, with Alveolar Ridge Preservation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The hypothesis tested in this clinical trial is that a biomimetic synthetic bone graft substitute (MimetikOss, Mimetis Biomaterials) with similar properties to those of human bone can reach a clinical outcome non inferior to that of a deproteinized bovine bone matrix bone graft substitute (Bio-Oss, Geistlisch) in an alveolar ridge preservation procedure followed by implant placement in terms of bone volume changes (primary end point), bone histological observation implant stability and bone level changes (secondary end points).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Biomimetic and immunomodulatory therapeutics as an alternative to natural exosomes for vascular and cardiac applications.
    Villarreal-Leal RA, Cooke JP, Corradetti B. · · 2021 · cited 13× · PMID 33774130 · DOI 10.1016/j.nano.2021.102385

Verify or expand the search:

Other recruiting trials for Alveolar Ridge Preservation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03374813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing